ConvEyXO, founded in 2019 by veterans of pharma industry, builds a specialized technology platform to convey exosome-based therapeutics to the market.
The company is developing is therapeutic portfolio in the field of fibrosis and chronic inflammatory disorders.
The rapid development of the company is the result of collaborations with partners with a demonstrated track record in healthtech and biotech fields
Company Details
- Employees
- 15
- Founded
- -
- Address
- Brussels South Charleroi Biopark, Gosselies,6041,belgium
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://conveyxo.com
- Keywords
- manufacturing, process development, upstream, downstream, extracellular vesicles, exosomes, therapeutics, cargo, Loading, 4D, exosomes.
- HQ
- Gosselies
Conveyxo Questions
Conveyxo's website is https://conveyxo.com
Conveyxo's LinkedIn profile is https://be.linkedin.com/company/conveyxo
Conveyxo has
15 employees.
View email and phone details for 15
employees at Conveyxo.
Conveyxo's industry is
Biotechnology Research
Conveyxo's top competitors are
Theratrame,
Iteos Therapeutics,
Abscint,
Celyad Oncology,
Exo Biologics,
Exothera,
Novadip Biosciences S.a.,
Stellaris Therapeutics,
Inhatarget Therapeutics,
Univercells.
Conveyxo's categories are Biotechnology Research
Conveyxo's founding year is 2019
